spacer
home > epc > Spring 2016
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2016

   
Text
PDF
bullet
Marketplace & Business
Pricing and Market Access

People Skills


According to a-connect's Aunia Grogan and Claire Hempshall, it is vital to establish and maintain access to drugs in an evolving environment, which is characterised by tight budgets, shifting market trends and new therapy areas, among others.


 
view
download pdf
bullet
Marketplace & Business: Translation Feature
Translation Tools

Lingua Franca


Translation technology has grown in conjunction with the increasing number of clinical trials carried out globally. Trevor Korb at Corporate Translations wonders how these new tools can aid pharma.

 
view
download pdf
bullet
Legal & Regulatory
Clinical Evaluation

Conform to the Norm: Part 2


Continuing from EPC February, Terry Winchell at GCP Innovative Dynamics further elaborates on current regulations concerning clinical investigator disqualifications, and shares practical advice.

 
view
download pdf
bullet
Electronic Solutions
Patient Communication Technology

Talk Technical


Dr Mark Hooper at Conversis Medical Translations observes how technology has an impact on nearly all areas in the pharma industry, and that patient adherence, communication, enrolment and retention can be improved as a result.

 
view
download pdf

Medical Writing
Medical Writing Metrics

Do You Measure Up?


There is a pressing need to measure the performance of service providers for evaluation purposes, states Trilogy Writing & Consulting’s Dr Julia Forjanic Klapproth, while emphasising that metrics for medical writing are not simple to establish.

 
view
download pdf

Interview
Q&A: Electronic Patient-Reported Outcomes

Digital Approach

John Sage
at iCardiac tells EPC about the increasing demand for ePRO technologies, which opens up significant growth opportunities for developers of such innovations.

 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

Stability Testing and Forced Degradation Stress Tests - Proactive Risk Management

Whereas the durability of many consumables, have a strong tendency to decrease, stability is and remains a crucial factor for pharmaceuticals. That is why the identification and elimination of factors, which put long-term stability at risk, is central during development – and an important requirement concerning the product’s quality.
More info >>

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>

Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement